机构:[1]Department of Nuclear Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.广东省中医院[2]Department of Hematology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.大德路总院血液科大德路总院血液科广东省中医院[3]Department of Ultrasound, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.大德路总院影像科大德路总院超声影像科广东省中医院[4]Department of Nuclear Medicine, Changhai Hospital, Navy Medical University, Shanghai, China.
第一作者机构:[1]Department of Nuclear Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.[*1]Department of NuclearMedicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, 111 Dade Rd, Yuexiu District, Guangzhou 510120, Guangdong Province, China
通讯作者:
通讯机构:[1]Department of Nuclear Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.[*1]Department of NuclearMedicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, 111 Dade Rd, Yuexiu District, Guangzhou 510120, Guangdong Province, China
推荐引用方式(GB/T 7714):
Ran Pengcheng,Li Hui,Hu Yongzhen,et al.FDG PET/CT of Primary Breast Lymphoma in a Man.[J].CLINICAL NUCLEAR MEDICINE.2022,47(5):447-448.doi:10.1097/RLU.0000000000003978.
APA:
Ran Pengcheng,Li Hui,Hu Yongzhen,Chen Miao&Dong Aisheng.(2022).FDG PET/CT of Primary Breast Lymphoma in a Man..CLINICAL NUCLEAR MEDICINE,47,(5)
MLA:
Ran Pengcheng,et al."FDG PET/CT of Primary Breast Lymphoma in a Man.".CLINICAL NUCLEAR MEDICINE 47..5(2022):447-448